Basal Insulin Therapy

Abstract

The present invention relates to the use of use of a long-acting insulin, in particular insulin glargine, in a method of reducing the risk of progression to type 2 diabetes in a patient, a method of reducing the risk of a new angina in a patient and a method of reducing the risk of a microvascular event in a patient comprising administering to said patient in need thereof a therapeutically effective dosage of a long acting insulin, wherein said therapeutically effective dosage of said long acting insulin reduces said risks.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 3, 2013
  • Application: Mar 28, 2013
    WO EP 2013056661 W
  • Priority: Sep 17, 2012
    US US 201261701911 P
  • Priority: May 11, 2012
    US US 201261645909 P
  • Priority: Apr 16, 2012
    US US 201261624598 P
  • Priority: Apr 3, 2012
    US US 201261619641 P
  • Priority: Mar 28, 2012
    US US 201261616768 P

Download Citation


Sign in to the Lens

Feedback